Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Alterity Therapeutics Limited (ATHE)

1.45   -0.05 (-3.33%) 07-08 11:01
Open: 1.45 Pre. Close: 1.5
High: 1.47 Low: 1.44
Volume: 148,306 Market Cap: 29M
Alterity Therapeutics Limited researches and develops therapeutic drugs for the treatment of Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidates include PBT434 that is in Phase I clinical trial for the treatment of Parkinson's disease and other movement disorders. It is also developing PBT2 for patients with Alzheimer's disease. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. The company was founded in 1997 and is based in Melbourne, Australia.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.573 - 1.583 1.583 - 1.59
Low: 1.429 - 1.441 1.441 - 1.449
Close: 1.484 - 1.502 1.502 - 1.515

Technical analysis

as of: 2020-07-08 10:25:25 AM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 2.74     One year: 3.21
Support: Support1: 1.24    Support2: 0.55
Resistance: Resistance1: 2.35    Resistance2: 2.74
Pivot: 0.97
Moving Average: MA(5): 1.60     MA(20): 0.88
MA(100): 0.67     MA(250): 0.86
MACD: MACD(12,26): 0.24     Signal(9): 0.14
Stochastic oscillator: %K(14,3): 53.15     %D(3): 57.16
RSI: RSI(14): 69.90
52-week: High: 2.35  Low: 0.28  Change(%): 22.7
Average Vol(K): 3-Month: 202702  10-Days: 995213

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
ATHE has closed below upper band by 24.2%. Bollinger Bands are 550.6% wider than normal. The large width of the bands suggest high volatility as compared to ATHE's normal range. The bands have been in this wide range for 5 bars. This is a sign that the current trend might continue.

Headline News

Tue, 07 Jul 2020
New Insight on Alterity Therapeutics Limited (ATHE) - Stocks Register

Mon, 06 Jul 2020
The Week Ahead In Biotech: Endo, Eagle Pharma FDA Decisions, ObsEva Late-Stage Readouts In Focus - Benzinga

Mon, 06 Jul 2020
35 Stocks Moving in Monday's Pre-Market Session - Benzinga

Thu, 02 Jul 2020
Is Alterity Therapeutics Ltd (ATHE) Stock a Top Performer in the Healthcare Sector? - InvestorsObserver

Thu, 02 Jul 2020
Alterity Therapeutics Limited (NASDAQ:ATHE) Finding Strong Support - The Oracle Dispatch

Thu, 02 Jul 2020
56 Biggest Movers From Yesterday - Benzinga

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NasdaqCM
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 15
Shares Float (M) 10
% Held by Insiders
% Held by Institutions 1.96
Shares Short (K) 12
Shares Short P. Month (K) 4

Stock Financials

EPS
EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin -288.55
Operating Margin
Return on Assets (ttm) -56.6
Return on Equity (ttm) -114.3
Qtrly Rev. Growth -23.5
Gross Profit (p.s.) 0.318
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio
PEG Ratio
Price to Book value
Price to Sales
Price to Cash Flow

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.